IFNα as induction and maintenance treatment of patients newly diagnosed with Waldenströmₑs macroglobulinemia

Journal of Interferon and Cytokine Research

Volumn 22, Issue 10, 2002, Pages 1013-1016

  Vela Ojeda, J ^a   GarciA Ruiz Esparza M A ^a   Padilla GonzaLez Y ^a   Rosas Cabral, A ^a   GarciA ChaVez J ^a   Xolotl Castillo, M ^a   Salazar Exaire, D ^b   Arenas Osuna, J ^b   AvinA Zubieta J A ^b   Vadillo Buenfil, M ^b   Abraham Majluf, A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital Especialidades C M La Raza   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; LACTATE DEHYDROGENASE; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON; ALPHA INTERFERON; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; FEVER; GRANULOCYTOPENIA; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MAINTENANCE THERAPY; MALE; MYALGIA; MYELOFIBROSIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SOMNOLENCE; SURVIVAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; DRUG COMBINATION; FIBROSIS; PATHOPHYSIOLOGY; REMISSION; TIME;

AGED; CHLORAMBUCIL; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; HUMANS; INTERFERON-ALPHA; L-LACTATE DEHYDROGENASE; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDNISONE; RECOMBINANT PROTEINS; REMISSION INDUCTION; TIME FACTORS; WALDENSTROM MACROGLOBULINEMIA;

EID: 1842855059     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999002760624233     Document Type: Article

References (18)

1. Waldenström, J. (1944). Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia: A new syndrome? Acta Med. Scand. 117, 216-247.
2. Groves, F.D., Travis, L.B., Devesa, S.S., Ries, L.A., and Fraumeni, J.F. (1998). Waldenström's macroglobulinemia: Incidence patterns in the United States, 1988-1994. Cancer 82, 1078-1081.
3. Waldenström, J.G. (1986). Macroglobulinemia: A review. Haematologica 71, 437-440.
4. Dimopoulos, M.A., and Alexanian, R. (1994). Waldenström's macroglobulinemia. Blood 83, 1452-1459.
5. Kyle, A.R., Greipp, P.R., Gertz, M.A., Witzig, T.E., LUST, J.A., LACY, M.Q., and THERNEAU, T.M. (2000). Waldenström's macroglobulinemia: A prospective study comparing daily with intermittent oral chlorambucil. Br. J. Haematol. 108, 737-742.
6. Foran, J.M., Rohatiner, A.Z.S., Coiffier, B., Barbui, T., Johnson, S.A., Hiddemann, W., Radford, J.A., Norton, A., Tollerfield, S.M., Wilson, M.P., and Lister, A. (1999). Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma. J. Clin. Oncol. 17, 546-553.
7. Fridrik, M.A., Jager, G., and Baldinger, C. (1997). Firstline treatment of Waldenström's disease with cladribine. Ann. Hematol. 74, 7-10.
8. Rotoli, B., De Renzo, A., Frigeri, F., Buffardi, S., Marceno, R., Cavallaro, A.M., Ruggeri, P., Liso, V., Musto, P., and Andriani, A. (1994). A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy. Leuk. Lymphoma 13, 463-469.
9. Levy, Y., Chedeville, A., and Brouet, J.C. (1996). Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia. Leuk. Lymphoma 23, 347-352.
10. Quesada, J.R., Alexanian, R., Kurzrock, R., Barlogie, B., Saks, S., and Gutterman, J.U. (1988). Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenström's macroglobulinemia. Am. J. Hematol. 29, 1-4.
11. De Rosa, G., De Renzo, A., Buffardi, S., and Rotoli, B. (1989). Treatment of Waldenstrom's macroglobulinemia with interferon. Haematologica 74, 313-315.
12. Bhavnani, M., Marples, J., and Yin, J.A. (1990). Treatment of Waldenström's macroglobulinemia with alpha interferon. J. Clin. Pathol. 43, 437.
13. Legouffe, E., Rossi, J.F., Laporte, J.P., Isnard, F., Oziol, E., Fabbro, M., Janbon, C., Jourdan, J., and Najman, A. (1995). Treatment of Waldenström's macroglobulinemia with very low doses of alpha interferon. Leuk. Lymphoma 19, 337-342.
14. Dimopoulos, M.A., Panayiotidis, P., Moulopoulos, L.A., Sfikakis, P., and Dalakas, M. (2000). Waldenström's macroglobulinemia: Clinical features, complications, and management. J. Clin. Oncol. 18, 214-226.
15. Monaco, S., Bonetti, B., Ferrari, S., Moretto, G., Nardelli, E., Tedesco, F., Mohines, T.E., Nobileorazio, E., Manfredini, E., and Bonazzi. L. (1990). Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N. Engl. J. Med. 322, 649-652.
16. Nobile-Orazio, E., Marmiroli, P., Baldini, L., Spagnol, G., Barbieri, S., Moggio, M., Polli, N., Polli, E., and Scarlato, G. (1987). Peripheral neuropathy in macroglobulinemia: Incidence and antigen specificity of M proteins. Neurology 37, 1506-1514.
17. Facon, T., Brouillard, M., and Duhamel, A. (1993). Prognostic factors in Waldenström's macroglobulinemia: A report of 167 cases. J. Clin. Oncol. 11, 1553-1558.
18. Barlogie, B., Smallwood, L., Smith, T., and Alexanian, R. (1989). High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma. Ann. Intern. Med. 110, 521-525.